ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
패혈증 치료제 시장 규모는 향후 몇 년 동안 강력한 성장을 보일 것으로 예상됩니다. 예측 기간 동안의 예상 성장은 항생제 내성 유행의 증가, 바이오마커 기반 진단의 채택 확대, 패혈증 치료에 대한 면역 요법의 중요성 강조, 개발도상국의 병원 인프라 확장, 패혈증 관리 개선을 위한 정부의 노력 등 여러 요인에 의해 촉진될 것입니다. 이 기간 동안의 주요 동향으로는 정밀 의학의 발전, 조기 패혈증 감지를 위한 AI 통합, 병용 요법의 증가, 새로운 패혈증 의약품에 대한 임상 시험의 증가, 신속한 분자 진단의 사용 확대 등이 있습니다.
감염성 질환의 유행이 증가함에 따라 패혈증 치료제 시장이 성장할 것으로 예상됩니다. 감염성 질환은 세균, 바이러스, 곰팡이, 기생충 등 유해 미생물에 의해 발생하며, 주로 기후 변화로 인해 증가하고 있습니다. 기온과 생태계의 변화는 모기 등 질병 매개체의 서식지를 확장시켜 말라리아와 뎅기열 같은 질병의 확산을 초래합니다. 패혈증 치료제는 감염 자체를 표적으로 삼아 염증을 줄이고 장기 기능을 지원하여 생명을 위협하는 합병증을 예방합니다. 미국 국립 의학 도서관에 따르면, 2023년 1월 현재 세계의 인구의 절반에 달하는 사람들이 감염성 질환의 위험에 처해 있으며, 이로 인해 매년 5,200만 명 이상이 사망하고 있습니다. 매년 약 1,400만 명의 5세 미만 어린이가 사망하고 있으며, 이 중 70%는 예방 접종을 통해 예방할 수 있는 질병으로 인해 사망하고 있습니다. 따라서 감염성 질환의 유행이 증가하는 것은 패혈증 치료제 시장의 성장을 촉진하는 주요 요인입니다.
패혈증 진단 시장 기업들은 패혈증의 조기 발견과 관리를 개선하기 위해 혁신적인 진단 기술 개발에 집중하고 있습니다. 신속한 분자 검사는 병원체를 빠르게 정확히 탐지할 수 있어 조기 진단, 환자 예후 개선, 지연된 진단으로 인한 사망률 감소에 필수적입니다. 이러한 신속한 분자 검사는 PCR 또는 등온 증폭과 같은 고급 기술을 활용해 병원체의 유전 물질을 탐지하여 식별합니다. 예를 들어, 2023년 11월, 미국에 본사를 둔 생명공학 기업인 Inflammatix Inc.는 TriVerity 급성 감염 및 패혈증 검사 시스템의 개발을 완료했다고 발표했습니다. 이 시스템에는 Myrna 장치와 TriVerity 카트리지가 포함되어 있으며, 응급실에서 감염이 의심되거나 패혈증 환자의 세균 또는 바이러스 감염 가능성과 급성 탈보상 위험을 평가하기 위해 설계되었습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 19 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 패혈증 치료제 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 패혈증 치료제 시장 : 성장률 분석
세계의 패혈증 치료제 시장 실적 : 규모와 성장(2019-2024년)
세계의 패혈증 치료제 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 패혈증치료제 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 패혈증 치료제 시장 : 약제 클래스별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세팔로스포린
아미노글리코시드
글리코펩티드
기타 약물 클래스
세계의 패혈증 치료제 시장 : 투여 경로별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
경구
주사제
국소제
세계의 패혈증 치료제 시장 : 유통 채널별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원 약국
소매 약국
온라인 약국
세계의 패혈증 치료제 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원
클리닉
기타 용도
세계의 패혈증 치료제 시장 세팔로스포린 유형별 세분화, 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제1세대 세팔로스포린
제2세대 세팔로스포린
제3세대 세팔로스포린
제4세대 세팔로스포린
제5세대 세팔로스포린
세계의 패혈증 치료제 시장 아미노글리코시드 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
겐타마이신
아미카신
토브라마이신
스트렙토마이신
기타 아미노글리코시드
세계의 패혈증 치료제 시장 글리코펩티드 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
반코마이신
테이코플라닌
달바반신
오리타반신
기타 글리코펩티드
세계의 패혈증 치료제 시장, 기타 약물 클래스 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
카르바페넴
β-락타마제 억제제
플루오로퀴놀론
마크로라이드
폴리믹신
제7장 지역별, 국가별 분석
세계의 패혈증 치료제 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 패혈증 치료제 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
패혈증 치료제 시장 : 경쟁 구도
패혈증 치료제 시장 : 기업 프로파일
Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
AstraZeneca plc : 개요, 제품 및 서비스, 전략 및 재무 분석
GSK plc : 개요, 제품 및 서비스, 전략 및 재무 분석
Eli Lilly and Company : 개요, 제품 및 서비스, 전략 및 재무 분석
Viatris Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Astellas Pharma Inc.
inthelia
La Jolla Pharmaceutical Co.
Cytovale Inc.
Aridis Pharmaceuticals Inc.
Partner Therapeutics Inc.
T2 Biosystems Inc.
Modus Therapeutics
InflaRx GmbH
Adrenomed AG
Sepsia Therapeutics
Endpoint Health
Prenosis Inc.
Spectral Medical Inc
Matisse Pharmaceuticals BV
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
패혈증 치료제 시장(2029년) : 새로운 기회를 제공하는 국가
패혈증 치료제 시장(2029년) : 새로운 기회를 제공하는 부문
패혈증 치료제 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
HBR
영문 목차
영문목차
Sepsis therapeutics refer to the medical treatments and medications specifically aimed at managing sepsis, a life-threatening condition triggered by the body's extreme response to infection. The primary objective of these treatments is to control the infection, sustain vital functions, manage inflammation, and avert organ failure, thereby enhancing survival rates and aiding in patient recovery.
The key drug categories used in sepsis treatment include cephalosporins, aminoglycosides, glycopeptides, among others. Cephalosporins, a class of broad-spectrum antibiotics, are frequently prescribed for sepsis and other serious bacterial infections. These drugs can be administered through various methods, such as orally, via injection, or topically. They are distributed through different channels, including hospital pharmacies, retail pharmacies, and online platforms. These medications are primarily used in settings such as hospitals, clinics, and other healthcare environments.
The sepsis therapeutics market research report is one of a series of new reports from The Business Research Company that provides sepsis therapeutics market statistics, including the sepsis therapeutics industry global market size, regional shares, competitors with the sepsis therapeutics market share, detailed sepsis therapeutics market segments, market trends, and opportunities, and any further data you may need to thrive in the sepsis therapeutics industry. This sepsis therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The sepsis therapeutics market size has grown rapidly in recent years. It will grow from $4.03 billion in 2024 to $4.43 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth observed in the historical period can be credited to factors such as the rising number of sepsis cases, heightened awareness surrounding early diagnosis and treatment, progress in antibiotic and antifungal therapies, increased healthcare spending, and regulatory backing for the advancement of sepsis treatments.
The sepsis therapeutics market size is expected to see strong growth in the next few years. It will grow to $6.41 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The projected growth in the forecast period is driven by factors such as the increasing prevalence of antimicrobial resistance, greater adoption of biomarker-based diagnostics, a growing emphasis on immunotherapy for sepsis treatment, expansion of hospital infrastructure in developing markets, and government efforts to enhance sepsis management. Key trends during this period include the development of precision medicine, integration of AI for early sepsis detection, a rise in combination therapies, an increase in clinical trials for new sepsis drugs, and an expanded use of rapid molecular diagnostics.
The growing prevalence of infectious diseases is expected to drive the sepsis therapeutics market forward. Infectious diseases, caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites, are on the rise, primarily due to climate change. Changing temperatures and ecosystems are expanding the habitats of disease-carrying vectors such as mosquitoes, leading to the spread of illnesses such as malaria and dengue fever. Sepsis therapeutics address these infectious diseases by targeting the infection itself, reducing inflammation, and supporting organ function to prevent life-threatening complications. According to the National Library of Medicine, in January 2023, infectious diseases are responsible for over 52 million deaths annually, with nearly half of the global population at risk. Each year, approximately 14 million children under five die, and 70% of these deaths are linked to preventable diseases that could be avoided through vaccination. Thus, the increasing prevalence of infectious diseases is a key factor driving the growth of the sepsis therapeutics market.
Companies in the sepsis diagnostics market are focused on developing innovative diagnostic technologies to improve sepsis detection and management. Advances in rapid molecular tests, which can detect pathogens quickly and accurately, are crucial for early diagnosis, better patient outcomes, and reduced mortality rates caused by delayed detection. These rapid molecular tests use advanced techniques such as PCR or isothermal amplification to identify pathogens by detecting their genetic material. For example, in November 2023, Inflammatix Inc., a US-based biotechnology company, announced the completion of its TriVerity Acute Infection and Sepsis Test System. This system includes the Myrna Instrument and the TriVerity Cartridge, designed for emergency department use to assess the likelihood of bacterial or viral infections and the risk of acute decompensation in patients with suspected infections and sepsis.
In January 2025, Partner Therapeutics, Inc. (PTx), a US-based biotechnology company specializing in sepsis therapeutics, partnered with the Biomedical Advanced Research and Development Authority (BARDA) to fund a Phase 2 study on the safety and optimal dosing of LEUKINE (sargramostim, rhu GM-CSF) in sepsis patients. This collaboration aims to enhance sepsis treatment by developing tools to measure immune status, enabling more targeted immunomodulatory therapies. BARDA, a US government department dedicated to biomedical advanced research, is supporting this initiative.
Major players in the sepsis therapeutics market are Pfizer Inc., AstraZeneca plc, GSK plc, Eli Lilly and Company, Viatris Inc., Astellas Pharma Inc., inthelia, La Jolla Pharmaceutical Co., Cytovale Inc., Aridis Pharmaceuticals Inc., Partner Therapeutics Inc., T2 Biosystems Inc., Modus Therapeutics, InflaRx GmbH, Adrenomed AG, Sepsia Therapeutics, Endpoint Health, Prenosis Inc., Spectral Medical Inc, Matisse Pharmaceuticals B.V.
North America was the largest region in the sepsis therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sepsis therapeutics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the sepsis therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The sepsis therapeutics market consists of revenues earned by entities providing services such as pharmaceutical interventions, supportive therapies, and diagnostic solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The sepsis therapeutics market also includes sales of antibiotics, intravenous fluids, vasopressors, and advanced therapies aimed at controlling infection, stabilizing patients, and preventing organ failure. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Sepsis Therapeutics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on sepsis therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for sepsis therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sepsis therapeutics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Drug Class: Cephalosporin; Aminoglycosides; Glycopeptide; Other Drug Classes
2) By Route Of Administration: Oral; Injectable; Topical
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
4) By Application: Hospitals; Clinics; Other Applications
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Sepsis Therapeutics Market Characteristics
3. Sepsis Therapeutics Market Trends And Strategies
4. Sepsis Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Sepsis Therapeutics Growth Analysis And Strategic Analysis Framework
5.1. Global Sepsis Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Sepsis Therapeutics Market Growth Rate Analysis
5.4. Global Sepsis Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Sepsis Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Sepsis Therapeutics Total Addressable Market (TAM)
6. Sepsis Therapeutics Market Segmentation
6.1. Global Sepsis Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cephalosporin
Aminoglycosides
Glycopeptide
Other Drug Classes
6.2. Global Sepsis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Injectable
Topical
6.3. Global Sepsis Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
6.4. Global Sepsis Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Other Applications
6.5. Global Sepsis Therapeutics Market, Sub-Segmentation Of Cephalosporin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
First-Generation Cephalosporins
Second-Generation Cephalosporins
Third-Generation Cephalosporins
Fourth-Generation Cephalosporins
Fifth-Generation Cephalosporins
6.6. Global Sepsis Therapeutics Market, Sub-Segmentation Of Aminoglycosides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gentamicin
Amikacin
Tobramycin
Streptomycin
Other Aminoglycosides
6.7. Global Sepsis Therapeutics Market, Sub-Segmentation Of Glycopeptide, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Vancomycin
Teicoplanin
Dalbavancin
Oritavancin
Other Glycopeptides
6.8. Global Sepsis Therapeutics Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Carbapenems
Beta-Lactamase Inhibitors
Fluoroquinolones
Macrolides
Polymyxins
7. Sepsis Therapeutics Market Regional And Country Analysis
7.1. Global Sepsis Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Sepsis Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Sepsis Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Sepsis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Sepsis Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Sepsis Therapeutics Market
9.1. China Sepsis Therapeutics Market Overview
9.2. China Sepsis Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Sepsis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Sepsis Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Sepsis Therapeutics Market
10.1. India Sepsis Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Sepsis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Sepsis Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Sepsis Therapeutics Market
11.1. Japan Sepsis Therapeutics Market Overview
11.2. Japan Sepsis Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Sepsis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Sepsis Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Sepsis Therapeutics Market
12.1. Australia Sepsis Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Sepsis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Sepsis Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Sepsis Therapeutics Market
13.1. Indonesia Sepsis Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Sepsis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Sepsis Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Sepsis Therapeutics Market
14.1. South Korea Sepsis Therapeutics Market Overview
14.2. South Korea Sepsis Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Sepsis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Sepsis Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Sepsis Therapeutics Market
15.1. Western Europe Sepsis Therapeutics Market Overview
15.2. Western Europe Sepsis Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Sepsis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Sepsis Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Sepsis Therapeutics Market
16.1. UK Sepsis Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Sepsis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Sepsis Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Sepsis Therapeutics Market
17.1. Germany Sepsis Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Sepsis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Sepsis Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Sepsis Therapeutics Market
18.1. France Sepsis Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Sepsis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Sepsis Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Sepsis Therapeutics Market
19.1. Italy Sepsis Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Sepsis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Sepsis Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Sepsis Therapeutics Market
20.1. Spain Sepsis Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Sepsis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Sepsis Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Sepsis Therapeutics Market
21.1. Eastern Europe Sepsis Therapeutics Market Overview
21.2. Eastern Europe Sepsis Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Sepsis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Sepsis Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Sepsis Therapeutics Market
22.1. Russia Sepsis Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Sepsis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Sepsis Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Sepsis Therapeutics Market
23.1. North America Sepsis Therapeutics Market Overview
23.2. North America Sepsis Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Sepsis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Sepsis Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Sepsis Therapeutics Market
24.1. USA Sepsis Therapeutics Market Overview
24.2. USA Sepsis Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Sepsis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Sepsis Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Sepsis Therapeutics Market
25.1. Canada Sepsis Therapeutics Market Overview
25.2. Canada Sepsis Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Sepsis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Sepsis Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Sepsis Therapeutics Market
26.1. South America Sepsis Therapeutics Market Overview
26.2. South America Sepsis Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Sepsis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Sepsis Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Sepsis Therapeutics Market
27.1. Brazil Sepsis Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Sepsis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Sepsis Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Sepsis Therapeutics Market
28.1. Middle East Sepsis Therapeutics Market Overview
28.2. Middle East Sepsis Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Sepsis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Sepsis Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Sepsis Therapeutics Market
29.1. Africa Sepsis Therapeutics Market Overview
29.2. Africa Sepsis Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Sepsis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Sepsis Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Sepsis Therapeutics Market Competitive Landscape And Company Profiles
